SUJAY KANGO Insider Trading $XLRN ACCELERON PHARMA INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SUJAY KANGO.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SUJAY KANGO. SUJAY KANGO is Chief Commercial Officer in INFINITY PHARMACEUTICALS, INC. ($INFI) and EVP, Chief Commercial Officer in ACCELERON PHARMA INC ($XLRN) and SVP, Chief Commercial Officer in ACCELERON PHARMA INC ($XLRN).

SUJAY KANGO in ACCELERON PHARMA INC

Trading Symbol: XLRN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SUJAY KANGO: EVP, Chief Commercial Officer, SVP, Chief Commercial Officer
Holdings: 24,396 shares
Current Value: $579,161
Latest Transaction: Mar 04 2021
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of SUJAY KANGO in ACCELERON PHARMA INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, XLRN, INFI

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 04 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...Option ExerciseM40.615,000203,05035,000
Mar 04 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...SellS138.1520027,63019,39619.6 K to 19.4 K (-1.02 %)
Mar 04 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...SellS137.1260082,27219,59620.2 K to 19.6 K (-2.97 %)
Mar 04 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...SellS136.241,501204,49620,19621.7 K to 20.2 K (-6.92 %)
Mar 04 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...SellS135.482,699365,66121,69724.4 K to 21.7 K (-11.06 %)
Mar 04 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...BuyM40.615,000203,05024,39619.4 K to 24.4 K (+25.78 %)
Feb 02 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...Option ExerciseA115.5320,8962,414,11520,896
Feb 02 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...GrantA0.005,409019,39614 K to 19.4 K (+38.67 %)
Jan 06 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...SellS126.154,624583,3183,9878.6 K to 4 K (-53.70 %)
Jan 06 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...SellS125.173,429429,2088,61112 K to 8.6 K (-28.48 %)
Jan 06 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...SellS123.901,947241,23312,04014 K to 12 K (-13.92 %)
Jan 06 2021XLRNACCELERON PHARMA I ...KANGO SUJAYEVP, Chief Commerci ...Payment of ExerciseF124.311,357168,68913,98715.3 K to 14 K (-8.84 %)
Jan 24 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...Option ExerciseA52.9924,3341,289,45924,334
Jan 24 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...GrantA0.006,369015,9399.6 K to 15.9 K (+66.55 %)
Jan 03 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...SellS51.27115649,5709.6 K to 9.6 K (-0.11 %)
Jan 03 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...SellS51.3746924,0939,58110.1 K to 9.6 K (-4.67 %)
Jan 03 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...SellS51.27115649,5709.6 K to 9.6 K (-0.11 %)
Jan 03 2020XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...SellS51.3746924,0939,58110.1 K to 9.6 K (-4.67 %)
Jan 29 2019XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...Option ExerciseA41.6425,5001,061,82025,500
Jan 29 2019XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...GrantA0.004,050010,0506 K to 10.1 K (+67.50 %)
Mar 05 2018XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...Option ExerciseA40.6150,0002,030,50050,000
Feb 13 2018XLRNACCELERON PHARMA I ...KANGO SUJAYSVP, Chief Commerci ...GrantA0.006,00006,0000 to 6 K

Page:   1

Contact us | Follow us on Twitter